GSTM1 and systemic lupus erythematosus: In conclusion, the current study provides preliminary evidence that the levels of C, ESR, and Hb, along with SLEDAI‐2K scores and urine protein test results, improve with the addition of belimumab to standard treatment in patients recently diagnosed with SLE.